165 related articles for article (PubMed ID: 16443684)
1. In vivo disruption of TGF-beta signaling by Smad7 leads to premalignant ductal lesions in the pancreas.
Kuang C; Xiao Y; Liu X; Stringfield TM; Zhang S; Wang Z; Chen Y
Proc Natl Acad Sci U S A; 2006 Feb; 103(6):1858-63. PubMed ID: 16443684
[TBL] [Abstract][Full Text] [Related]
2. Protection of cerulein-induced pancreatic fibrosis by pancreas-specific expression of Smad7.
He J; Sun X; Qian KQ; Liu X; Wang Z; Chen Y
Biochim Biophys Acta; 2009 Jan; 1792(1):56-60. PubMed ID: 19015026
[TBL] [Abstract][Full Text] [Related]
3. The TGF-beta signaling inhibitor Smad7 enhances tumorigenicity in pancreatic cancer.
Kleeff J; Ishiwata T; Maruyama H; Friess H; Truong P; Büchler MW; Falb D; Korc M
Oncogene; 1999 Sep; 18(39):5363-72. PubMed ID: 10498890
[TBL] [Abstract][Full Text] [Related]
4. Conditional expression of Smad7 in pancreatic beta cells disrupts TGF-beta signaling and induces reversible diabetes mellitus.
Smart NG; Apelqvist AA; Gu X; Harmon EB; Topper JN; MacDonald RJ; Kim SK
PLoS Biol; 2006 Feb; 4(2):e39. PubMed ID: 16435884
[TBL] [Abstract][Full Text] [Related]
5. Angiotensin II promotes the proliferation of activated pancreatic stellate cells by Smad7 induction through a protein kinase C pathway.
Hama K; Ohnishi H; Aoki H; Kita H; Yamamoto H; Osawa H; Sato K; Tamada K; Mashima H; Yasuda H; Sugano K
Biochem Biophys Res Commun; 2006 Feb; 340(3):742-50. PubMed ID: 16380081
[TBL] [Abstract][Full Text] [Related]
6. Smad signaling pathways regulate pancreatic endocrine development.
El-Gohary Y; Tulachan S; Guo P; Welsh C; Wiersch J; Prasadan K; Paredes J; Shiota C; Xiao X; Wada Y; Diaz M; Gittes G
Dev Biol; 2013 Jun; 378(2):83-93. PubMed ID: 23603491
[TBL] [Abstract][Full Text] [Related]
7. Origin of pancreatic ductal adenocarcinoma from atypical flat lesions: a comparative study in transgenic mice and human tissues.
Aichler M; Seiler C; Tost M; Siveke J; Mazur PK; Da Silva-Buttkus P; Bartsch DK; Langer P; Chiblak S; Dürr A; Höfler H; Klöppel G; Müller-Decker K; Brielmeier M; Esposito I
J Pathol; 2012 Apr; 226(5):723-34. PubMed ID: 21984419
[TBL] [Abstract][Full Text] [Related]
8. TGF-beta superfamily signaling is essential for tooth and hair morphogenesis and differentiation.
Klopcic B; Maass T; Meyer E; Lehr HA; Metzger D; Chambon P; Mann A; Blessing M
Eur J Cell Biol; 2007 Dec; 86(11-12):781-99. PubMed ID: 17499880
[TBL] [Abstract][Full Text] [Related]
9. Cerulein-induced pancreatic fibrosis is modulated by Smad7, the major negative regulator of transforming growth factor-β signaling.
Li X; Nania S; Fejzibegovic N; Moro CF; Klopp-Schulze L; Verbeke C; Löhr JM; Heuchel RL
Biochim Biophys Acta; 2016 Sep; 1862(9):1839-46. PubMed ID: 27349482
[TBL] [Abstract][Full Text] [Related]
10. Expression of a dominant-negative mutant TGF-beta type II receptor in transgenic mice reveals essential roles for TGF-beta in regulation of growth and differentiation in the exocrine pancreas.
Böttinger EP; Jakubczak JL; Roberts IS; Mumy M; Hemmati P; Bagnall K; Merlino G; Wakefield LM
EMBO J; 1997 May; 16(10):2621-33. PubMed ID: 9184209
[TBL] [Abstract][Full Text] [Related]
11. In vivo disruption of TGF-beta signaling by Smad7 in airway epithelium alleviates allergic asthma but aggravates lung carcinogenesis in mouse.
Luo X; Ding Q; Wang M; Li Z; Mao K; Sun B; Pan Y; Wang Z; Zang YQ; Chen Y
PLoS One; 2010 Apr; 5(4):e10149. PubMed ID: 20405019
[TBL] [Abstract][Full Text] [Related]
12. Inhibitory Smad7: emerging roles in health and disease.
Briones-Orta MA; Tecalco-Cruz AC; Sosa-Garrocho M; Caligaris C; Macías-Silva M
Curr Mol Pharmacol; 2011 Jun; 4(2):141-53. PubMed ID: 21222648
[TBL] [Abstract][Full Text] [Related]
13. Smad4 loss synergizes with TGFα overexpression in promoting pancreatic metaplasia, PanIN development, and fibrosis.
Garcia-Carracedo D; Yu CC; Akhavan N; Fine SA; Schönleben F; Maehara N; Karg DC; Xie C; Qiu W; Fine RL; Remotti HE; Su GH
PLoS One; 2015; 10(3):e0120851. PubMed ID: 25803032
[TBL] [Abstract][Full Text] [Related]
14. Effect of Smad7 expression on metastasis of mouse mammary carcinoma JygMC(A) cells.
Azuma H; Ehata S; Miyazaki H; Watabe T; Maruyama O; Imamura T; Sakamoto T; Kiyama S; Kiyama Y; Ubai T; Inamoto T; Takahara S; Itoh Y; Otsuki Y; Katsuoka Y; Miyazono K; Horie S
J Natl Cancer Inst; 2005 Dec; 97(23):1734-46. PubMed ID: 16333029
[TBL] [Abstract][Full Text] [Related]
15. Smad7 induces tumorigenicity by blocking TGF-beta-induced growth inhibition and apoptosis.
Halder SK; Beauchamp RD; Datta PK
Exp Cell Res; 2005 Jul; 307(1):231-46. PubMed ID: 15922743
[TBL] [Abstract][Full Text] [Related]
16. Chronic exposure of transforming growth factor beta 1 confers a more aggressive tumor phenotype through downregulation of p21(WAF1/CIP1) in conditionally immortalized pancreatic epithelial cells.
Ito D; Fujimoto K; Doi R; Koizumi M; Toyoda E; Mori T; Kami K; Kawaguchi Y; Whitehead R; Imamura M
Surgery; 2004 Aug; 136(2):364-74. PubMed ID: 15300203
[TBL] [Abstract][Full Text] [Related]
17. Elevating CLIC4 in Multiple Cell Types Reveals a TGF- Dependent Induction of a Dominant Negative Smad7 Splice Variant.
Shukla A; Yang Y; Madanikia S; Ho Y; Li M; Sanchez V; Cataisson C; Huang J; Yuspa SH
PLoS One; 2016; 11(8):e0161410. PubMed ID: 27536941
[TBL] [Abstract][Full Text] [Related]
18. Smad7: not only a regulator, but also a cross-talk mediator of TGF-β signalling.
Yan X; Chen YG
Biochem J; 2011 Feb; 434(1):1-10. PubMed ID: 21269274
[TBL] [Abstract][Full Text] [Related]
19. Smad7 transgene attenuates peritoneal fibrosis in uremic rats treated with peritoneal dialysis.
Guo H; Leung JC; Lam MF; Chan LY; Tsang AW; Lan HY; Lai KN
J Am Soc Nephrol; 2007 Oct; 18(10):2689-703. PubMed ID: 17855642
[TBL] [Abstract][Full Text] [Related]
20. Crk-associated substrate lymphocyte type regulates transforming growth factor-beta signaling by inhibiting Smad6 and Smad7.
Inamoto S; Iwata S; Inamoto T; Nomura S; Sasaki T; Urasaki Y; Hosono O; Kawasaki H; Tanaka H; Dang NH; Morimoto C
Oncogene; 2007 Feb; 26(6):893-904. PubMed ID: 16909115
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
